Insider · CIK 0001638643
Daniel Patrick O'Day
ceochairofficerdirector
Files at GILD (GILEAD SCIENCES, INC.). First filing Sep 2, 2026, latest Oct 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $4.4M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GILD: GILEAD SCIENCES, INC.
GILDOct 9, 2026 · close 151.17
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | GILEAD SCIENCES, INC. | $2.2M 15,000 shares | -3% | +37% from low · -4% from high | |
| 45Moderate | GILEAD SCIENCES, INC. | $2.2M 15,000 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -12,000 | $147.72 | $1.8M | 569,683 | 9 d ago |
| Oct 1, 2026 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -3,000 | $148.63 | $446k | 566,683 | 9 d ago |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock | +8,780 | - | - | 585,913 | 30 d ago |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -4,230 | $144.81 | $613k | 581,683 | 30 d ago |
| Sep 10, 2026 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative | -8,780 | - | - | 83,300 | 30 d ago |
| Sep 1, 2026 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -1,600 | $147.51 | $236k | 590,533 | 39 d ago |
| Sep 1, 2026 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -7,992 | $148.36 | $1.2M | 582,541 | 39 d ago |
| Sep 1, 2026 | GILD GILEAD SCIENCES, INC. | SOpen-market sale Common Stock10b5-1 | -5,408 | $149.38 | $808k | 577,133 | 39 d ago |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock | +24,024 | - | - | 641,900 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -11,632 | $117.21 | $1.4M | 630,268 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative | -24,024 | - | - | 80,953 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +169,690 | $0.00 | $0 | 169,690 | Mar 12, 2025 |
| Mar 10, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Restricted Stock Unitderivative | +38,395 | - | - | 119,348 | Mar 12, 2025 |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +60,031 | $0.00 | $0 | 561,559 | Feb 6, 2025 |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +164,473 | $0.00 | $0 | 726,032 | Feb 6, 2025 |
| Feb 4, 2025 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -108,156 | $97.99 | $11M | 617,876 | Feb 6, 2025 |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock | +10,295 | - | - | 506,290 | Dec 11, 2024 |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -4,762 | $92.34 | $440k | 501,528 | Dec 11, 2024 |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative | -10,295 | - | - | 104,977 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.